LeMaitre Vascular, Inc.
LeMaitre Vascular develops, manufactures, and markets medical devices for vascular surgery worldwide. The company offers various products including angioscope, embolectomy catheters, thrombectomy catheters, occlusion catheters, and perfusion catheters. They also provide biologic grafts, patches, carotid shunts, biosynthetic vascular grafts, and vascular grafts for bypass or replacement of diseased arteries. Additionally, they offer radiopaque tape to locate tributaries or lesions beneath the skin. Valvulotomes are used to cut or disrupt valves in the saphenous vein. Closure systems attach vessels with titanium clips instead of sutures. The company markets its products through a direct sales force and distributors.
Overview
Sector
Medical Instruments & Supplies
Strengths
- Shows the financial signature of a durable competitive advantage (economic moat): returns well above its cost of capital, an asset-light, cash-generative model and operating margins that held up every year.
- Creates economic value: ROIC of 14.0% against a cost of capital (WACC) of 6.5%, a spread of 7.6 percentage points.
- Asset-light, cash-generative model: capital expenditure takes only 2.9% of revenue and free cash flow was positive in each of the last 6 years.
- Resilient profitability: operating margin stayed between 19% and 27% in each of the last 6 years.
- Consistent growth: revenue has compounded at 14.0% a year over 5 years, rising every year.
- Improving fundamentals over the last year: return on assets up 1.4 points and gross margin up 2.9 points.
Weaknesses
- Our discounted cash flow target price (52.68 USD) is 37% below the current price.
- Valued at a premium to its Medical Instruments & Supplies peers: EV/EBITDA 26.5x vs. a median of 16.0x.
Key Financial Data